Today: 2 February 2026
Subscribe
Browse Category

NYSE:TTC News 17 December 2025

The Toro Company (TTC) Stock Surges After Q4 FY2025 Earnings Beat and FY2026 Guidance — What Investors Are Watching

The Toro Company (TTC) Stock Surges After Q4 FY2025 Earnings Beat and FY2026 Guidance — What Investors Are Watching

The Toro Company (NYSE: TTC) is in focus on December 17, 2025, after the outdoor equipment and professional turf/landscape solutions maker reported fourth-quarter and full-year fiscal 2025 results (fiscal year ended October 31, 2025) alongside its fiscal 2026 outlook. The immediate takeaway for markets: results came in better than consensus expectations on key headline metrics, and management outlined a 2026…
17 December 2025
·····

Stock Market Today

  • Cantor Fitzgerald Raises Price Target for Regeneron Pharmaceuticals (NASDAQ:REGN)
    February 2, 2026, 11:58 AM EST. Cantor Fitzgerald increased its price target on Regeneron Pharmaceuticals (NASDAQ:REGN) from $740 to $800, maintaining an "overweight" rating, signaling a potential 5% upside. Other brokerages also raised forecasts, with BMO Capital Markets at $850, Guggenheim at $865, and Evercore ISI at $875. Regeneron's shares rose 2.7% to $761.32 amid increased trading volume. The biotech giant posted strong Q4 results with EPS of $11.44 beating estimates, and revenues up 2.5% year-over-year to $3.88 billion. The company holds a solid balance sheet with low debt and robust margins. Market consensus rates the stock as a "Moderate Buy" with an average price target near $790, reflecting optimism about Regeneron's growth prospects.
Go toTop